Showing results (31-40 of 69) with videos related to
Sort By:
Pageof 7
Antimicrobial Agents and Chemotherapy|April 25, 2013
Molecular characterization of blaNDM-1 in a sequence type 235 Pseudomonas aeruginosa isolate from FranceFrédéric Janvier, Katy Jeannot, Sophie Tessé, et al.Microbiology Resource Announcements|June 15, 2023
Whole-Genome Sequencing of 11 High-Risk Clone ST111 Pseudomonas aeruginosa Isolates from French HospitalsMikkel Anbo, Mariana Antonova Tavares Chichkova, Yilmaz Emre Gençay, et al.International Journal of Molecular Sciences|February 11, 2023
Poly-L-Lysine to Fight Antibiotic Resistances of Pseudomonas aeruginosaAdeline Cezard, Delphine Fouquenet, Virginie Vasseur, et al.Environmental Microbiology|February 26, 2016
Phenotype and toxicity of the recently discovered exlA-positive Pseudomonas aeruginosa strains collected worldwideEmeline Reboud, Sylvie Elsen, Stéphanie Bouillot, et al.Plos One|December 18, 2014
Molecular epidemiology of carbapenem non-susceptible Acinetobacter baumannii in FranceKaty Jeannot, Laure Diancourt, Sophie Vaux, et al.Journal of Global Antimicrobial Resistance|June 6, 2024
Should we, and how to, optimize cefiderocol administration during severe nosocomial pneumonia due to carbapenem-resistant Acinetobacter baumanii? A viewpointJulien Massol, Aurélien Dinh, Katy Jeannot, et al.Antimicrobial Agents and Chemotherapy|September 19, 2019
Acquisition of class C β-lactamase PAC-1 by ST664 strains of Pseudomonas aeruginosaMaxime Bour, Damien Fournier, Thomas Jové, et al.Annals of Clinical Microbiology and Antimicrobials|August 22, 2024
Commercially available tests for determining cefiderocol susceptibility display variable performance in the Achromobacter genusVincent Jean-Pierre, Pauline Sorlin, Katy Jeannot, et al.Annals of Clinical Microbiology and Antimicrobials|June 17, 2024
Cefiderocol susceptibility of Achromobacter spp.: study of an accurately identified collection of 230 strainsVincent Jean-Pierre, Pauline Sorlin, Alix Pantel, et al.Infectious Diseases and Therapy|January 31, 2026
Role of Cefiderocol in the Treatment of Carbapenem-Resistant Nonfermenting Gram-Negative Bacilli (Acinetobacter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia) Infections: An Expert StatementAlexandre Bleibtreu, Youssef Bennis, Aurélien Dinh, et al.Pageof 7